Intelligent Bio Solutions
INBS
3 hedge funds and large institutions have $24.3K invested in Intelligent Bio Solutions in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
188% more capital invested
Capital invested by funds: $8.45K → $24.3K (+$15.9K)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.4K |
| 2 |
OP
ORG Partners
Roanoke,
Indiana
|
+$9.53K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.67K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $13K | +$23.4K | +103 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $6.12K | +$5.67K | +25 | +100% |
|
|
OP
3
ORG Partners
Roanoke,
Indiana
| $5.15K | +$9.53K | +42 | New |
|
4
Wells Fargo
San Francisco,
California
| $18 | – | – | – |
|
INBS Hedge Fund Activity: Q3 2023 in Review
3 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2023, worth a combined $24.3K — up 188% from $8.45K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new INBS positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $23.4K.
- 3 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2023, up from 1 in Q2 2023.
- Funds reported $24.3K of Intelligent Bio Solutions stock for Q3 2023, up 188% quarter-over-quarter.
- 2 funds opened new Intelligent Bio Solutions positions in Q3 2023 and 0 closed out, a net change of +2 holders.
- The largest Intelligent Bio Solutions buyer in Q3 2023 was Geode Capital Management, an estimated $23.4K added.
Based on aggregated 13F filings for Q3 2023.